NEW YORK (GenomeWeb News) – Bruker today said that it has already received more than 100 systems orders associated with various global stimulus funding programs.

The firm said that all five of its operating divisions have received stimulus orders for instruments such as mass spectrometry, NMR, pre-clinical MRI, and X-ray. Bruker estimated the average selling prices of these orders were greater than $500,000 per system — and the total amount of stimulus orders it received in the second half of 2009 exceeded $70 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.